NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

25 hedge funds and large institutions have $2.17M invested in InVivo Therapeutics Holdings Corp in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$31K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$113K
2
+$102K
3
+$86K
4
TSS
Two Sigma Securities
New York
+$40K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$30.2K

Top Sellers

1
-$255K
2
-$163K
3
-$91K
4
Goldman Sachs
Goldman Sachs
New York
-$57K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$36K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$3K
28
$3K
29
$2K
30
$2K
31
$1K
32
–
33
–
34
–
35
–
36
–
37
–
38
–
1
2